✦ LIBER ✦

Treatment of breast cancer with oral four-drug chemotherapy

✍ Scribed by John F. Foley; M. Anne Kessinger; Henry M. Lemon

Publisher: John Wiley and Sons
Year: 1980
Tongue: English
Weight: 369 KB
Volume: 14
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.2930140110

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy in the treatment strategy o

Chemotherapy in the treatment strategy of breast cancer

✍ Dr. Paul P. Carbone 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB 👁 2 views

Although breast cancer presents as localized disease and is treated with local modalities, i.e. surgery and radiotherapy, patients die with metastatic disease. For patients with positive nodes, the recurrence rates are well known. It is this group of patients who should receive more aggressive trea

Preoperative chemotherapy treatment of b

Preoperative chemotherapy treatment of breast cancer—A review

✍ Aman U. Buzdar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

## Abstract Despite proven benefits of neoadjuvant chemotherapy in patients with locally advanced, invasive breast cancer, no regimen is recommended as the treatment of choice. Neoadjuvant chemotherapy regimens encompass single‐agent and combination therapy and sequential treatment. For this report

Combination chemotherapy in the treatmen

Combination chemotherapy in the treatment of advanced breast cancer

✍ Dutzu Rosner; Takuma Nemoto; Chief Thomas L. Dao 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

## Abstract Seventy‐two women with metastatic breast cancer were treated with multiple‐agent chemotherapy. Fifty women were treated with 5 drugs in combination: 5‐FU, methotrexate, vincristine, cytoxan, and prednisone; 22 were treated with the combination of 3 drugs: 5‐FU, cytoxan, and prednisone.

Conservative treatment (chemotherapy/rad

Conservative treatment (chemotherapy/radiotherapy) of locally advanced breast cancer

✍ Michel Héary; Moise Namer; Michel Moro; Jean-Louis Boublil; Claude M. Lalanne 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 654 KB

Oral medroxyprogesterone in the treatmen

Oral medroxyprogesterone in the treatment of metastatic breast cancer

✍ Takuma Nemoto; Jashbha1 Patel; Dutzu Rosner; Thomas L. Dao 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

In 47 postmenopausal women with evaluable breast cancer, oral medroxyprogesterone acetate (MPA) was given at a daily dose level of 400 mg. Patients with negative estrogen receptors, poor performance status , or nonresponse to previous endocrine therapy were excluded from this study. There were 25 (

Secondary drug resistance in breast canc

Secondary drug resistance in breast cancer: Failure to reverse with oral nifedipine

✍ Frankie Ann Holmes; Arsenio Lopez; Giora Mavligit; Giuseppe Fraschini; Debra Fry 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 37 KB 👁 2 views

We tested the efficacy of nifedipine to reverse acquired resistance to chemotherapy regimens containing doxorubicin or vinblastine or both in 12 patients with metastatic breast cancer. All patients had been receiving one or both of these drugs, had had a prior partial response (median duration 5 mon